Vaccinations

University of Oxford launches first human aerosol TB vaccine trial

The University of Oxford has commenced a new clinical trial called TB-45, which will test the safety of a new tuberculosis (TB) vaccine.

Sinovac vaccine performs at 83.5% in Phase Three trial

New data from Phase Three of the Sinovac vaccine trial shows that the drug is now performing at 83.5%.

Pfizer to create COVID vaccine against Delta variant

Pfizer say they will develop a new COVID vaccine to function as a booster against the Delta variant.

9 in 10 adults have COVID-19 antibodies, according to new survey

A new Government survey has found that 9 in 10 adults have COVID-19 antibodies, but experts say more data is needed before 'Freedom Day'.

Study finds natural immune response not effective against COVID variants

An Australian team found that antibodies created by infection with the virus are not effective against COVID variants - suggesting that vaccination gives stronger protection.

Supporting vaccination campaigns through high-quality cold storage solutions

Arthur Goudena, Marketing Manager of PHC Europe, explains how the company’s cold storage solutions are available to support COVID-19 vaccination campaigns across Europe.

Is the Lambda variant more infectious than Delta?

The Lambda variant, originating in Peru, has been found in 32 countries - but for the moment, it remains classified as a less threatening Variant of Interest.

SAGE report: More infections will increase ethnic minority COVID deaths

SAGE say the UK Governments' plans to lift all social distancing measures on 19 July are too much - they believe a rise in infections will increase ethnic minority COVID deaths.

UK study says saRNA COVID vaccines work in 87% of people

While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.

UK study says safe to mix Pfizer and AstraZeneca doses

A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.

WHO says double-vaccinated people should wear masks

The World Health Organisation says that double-vaccinated people should wear masks due to the rising threat of the Delta variant, as the UK considers dropping mandatory mask measures after 'unlockdown'.

UK to give third COVID dose for over-50s before winter

The UK Government will begin rollout of a third COVID dose for over-50s and vulnerable individuals, with the NHS given the go-ahead to create their pre-winter vaccination plan.

Study reveals 94% of cancer patients react well to COVID vaccine

According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.

13% of global COVID-19 deaths are in Brazil

With 2.7% of the world's population, but 13% of COVID-19 deaths globally, Brazil continues to suffer a disproportional death rate.

REACT study: Women in UK have higher chance of long COVID

New data from the ongoing REACT study found that over two million people in the UK are known to have experienced long COVID.

Delta variant responsible for one in five US COVID cases

The Delta variant, originating in India, is now responsible for one in five US COVID cases, according to new information from Dr Anthony Fauci.

Real-time symptom tracking for long COVID

Katrina Delargy, Managing Director of TIYGA Health, tells us what we need to know about real-time symptom tracking for long COVID.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders